Atypical headache and facial pain as a result of hypertrophic pachymeningitis in C-ANCA-positive Wegener's granulomatosis;Atypischer kopf- und gesichtsschmerz infolge hypertropher pachymeningitis bei C-ANCA positivem morbus Wegener

Medizinische Klinik

Volumn 100, Issue 4, 2005, Pages 209-212

  Kuhn, Jens ^a   Weber, Manfred ^a   Hedde, Jan Peter ^a   Bewermeyer, Heiko ^a  

^a KRANKENHAUS MERHEIM   (Germany)

Author keywords

Atypical headache; C ANCA; Cerebrospinal fluid; Hypertrophic pachymeningitis; Wegener's granulomatosis

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CASE REPORT; CEREBELLUM TENTORIUM; CEREBROSPINAL FLUID; CONTRAST ENHANCEMENT; DISEASE DURATION; DISEASE SEVERITY; DRUG MEGADOSE; FACE PAIN; FOLLOW UP; HEADACHE; HUMAN; HYPERTROPHIC PACHYMENINGITIS; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MENINGITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAMETER; PATIENT; WEGENER GRANULOMATOSIS;

ADRENAL CORTEX HORMONES; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; DRUG THERAPY, COMBINATION; FACIAL PAIN; FEMALE; FOLLOW-UP STUDIES; HEADACHE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MENINGITIS; TIME FACTORS; WEGENER GRANULOMATOSIS;

EID: 17744372332     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-005-1023-3     Document Type: Article

References (23)

1. Agdal N. Hagdrup HK, Wantzin GL. Pachymeningids cervicalis hypertrophica syphilitica. Acta Derm Venereol 1980;60:184-6.
2. Callebaut J, Dormont D, Dubois B, et al. Contrast-enhanced MR imaging of tuberculous pachymeningitis cranialis hypertrophica: case report. AJNTR Am J Nenroradiol 1990;11:821-2.
3. De Groot K, Schmidt DK, Arlt AC, et al. Standardized neurologic evaluations of 128 patients with Wegener granulomatosis. Arch Nenrol 2001;58:1215-21.
4. Drachman DD. Neurological complications of Wegeners granulomatosis. Arch Neurol 1963;8:145-55.
5. Fam AG, Lavine E, Lee L, et al. Cranial pachymeningitis: an unusual manifestation of Wegener's granulomatosis. J Rheumatol 2003;30:2070-4.
6. Fauci AS, Haynes BF, Katz P, et al.Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76-85.
7. Goyal M, Malik A, Mishra NK, et al. Idiopathic hypertrophic pachymeningitis: spectrum of the disease. Neuroradiology 1997:39:619-23.
8. Jinnah HA, Dixon A, Brat DJ, et al. Chronic meningitis with cranial neuropathies in Wegener's granulomatosis. Case report and review of the literature. Arthritis Rheum 1997:40:573-7.
9. Joelson E, Ruthrauff B, Ali F, et al. Multifocal dural enhancement associated with temporal arteritis. Arch Neurol 2000:57:119-22.
10. Kuhn J, Bewermeyer H. Kopf- und Gesichtsschmerzen. In: Conen D, Griebenow R, Meuthen I, et al., Hrsg.: Internistische Differenzialdiagnostik. Klinische Pfade und Entscheidungsprozesse in Flussdiagrammen, 5. Auflage Stuttgart: Schattauer: in Vorbereitung.
11. Kuhn J, Harzheim A, Mahkorn D, et al. Focal hypertrophic pachymeningitis in association with temporal arteritis. Headache 2004;44:1045-8.
12. Kupersmith MJ, Martin V, Heller G, et al. Idiopathic hypertrophic pachymeningitis. Neurology 2004;62:686-94.
13. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
14. Li JY, Lai PH, Lam HC, et al. Hypertrophic cranial pachymeningitis and lymphocytic hypophysitis in Sjögren's syndrome. Neurology 1999;52:420-3.
15. Nagashima T, Maguchi S, Terayama Y, et al. P-ANCA - positive Wegener's granulomatosis presenting with hypertrophic pachymeningitis and multiple cranial neuropathies: case report and review of literature. Neuropathology 2000;20:23-30.
16. Nishino H, Rubino FA, DeRemee RA, et al. Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol 1993;33:4-9.
17. Nonaka N, Yamazaki M, Onishi Y, et al. An autopsied case of pachymeningitis associated with a ruptured, cerebral aneurysm due to Aspergillus infection. Rinsho Shinkeigaku 2001;41:673-8.
18. Sherman JL, Stern BJ. Sarcoidosis of the CNS: comparison of unenhanced and enhanced MR images. AJNR Am J Neuroradiol 1990:11:915-23.
19. Specks U, Moder KG, McDonald TJ. Meningeal involvement in Wegener granulomatosis. Mayo Clin Proc 2000;75:856-9.
20. Spranger M, Schwab S, Meinck HM, et al. Meningeal involvement in Wegener's granulomatosis confirmed and monitored by positive circulating antineutrophil cytoplasm in cerebrospinal fluid. Neurology 1997:48:263-5.
21. Tishler S, Williamson T, Mirra SS, et al. Wegener granulomatosis with meningeal involvement. AJNR Am J Neuroradiol 1993;14:1248-52.
22. Weber MF, Andrassy K, Pullig O, et al. Antineutrophilcytoplasmic antibodies and antiglomerular basement membrane antibodies in Goodpasture's syndrome and in Wegener's granulomatosis. J Am Soc Nephrol 1992;2:1227-34.
23. Yuh WT, Drew JM, Rizzo M, et al. Evaluation of pachymeningitis by contrast-enhanced MR imaging in a patient with rheumatoid disease. AJNR Am J Neuroradiol 1990;11:1247-8.